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Summary 
We reviewed the effect of behavioural telehealth interventions in type 2 diabetes on 
glycaemic control and diabetes self-management.  The databases CINAHL, Medline and 
psychINFO were searched in August 2012.  Peer-reviewed journal articles that were 
published in English with a randomised controlled trial design using a usual care comparison 
group, and in which the primary intervention component was delivered by telehealth, were 
selected.  Relevant outcome measures were glycaemic control and one or more diabetes self-
care area of: diet, physical activity, blood glucose self-monitoring (BGSM) or medication 
adherence. Interventions were excluded if they were primarily based on a telemonitoring.  
The search retrieved 1027 articles, from which 49 were selected based on their title and 
abstract.  Fourteen articles (reporting 13 studies) met the eligibility criteria for inclusion.  
Four studies reported significant improvements in glycaemic control.  Five of eight studies on 
dietary adherence reported significant treatment effects, as did five of eight on physical 
activity, four of nine on blood glucose self-monitoring, and three of eight on medication 
adherence.  Overall, behavioural telehealth interventions show promise in improving the 
diabetes self-care and glycemic control of people with type 2 diabetes. 
 
 
Introduction 
Diabetes is responsible for the eighth-highest burden of disease in Australia.  Type 2 diabetes 
accounts for 92% of the burden due to diabetes,1 and affects 3.8% of Australians.2 Glycaemic 
control is strongly associated with diabetes-related morbidity and mortality,3 with higher 
glycaemia predicting increased physical, mental, psychological and psychosocial 
comorbidities.  Improvements in glycaemia to the recommended glycosylated haemoglobin 
(HbA1c) level of ≤7%4 are significantly related to a reduced risk of micro- and macro-
vascular complications.5  Maintaining essential diabetes self-care practises that include 
regular physical activity, healthy eating, blood glucose self-monitoring (BGSM) and 
medication adherence is integral to achieving this.4 However the majority of diabetes patients 
remain poorly controlled (HbA1c≥8%), which indicates that regular, accessible and effective 
type 2 diabetes self-management support is required. 
 
Telehealth may assist type 2 diabetes patients by improving accessibility to health care 
services.  This may be of particular importance in rural and regional areas.  Currently 26% 
(230,700) of Australians with diabetes live in inner regional, and 12% (110,400) in outer 
regional or remote areas.6 Whilst general practitioners (GPs) are the primary care providers 
for patients with type 2 diabetes, only 20% of all GPs are based outside metropolitan city 
areas.7 Telehealth also presents a convenient, cost-effective way for patients with mobility or 
motivational problems to receive regular support, including the elderly and patients with 
complicated diabetes. 
 
Telehealth applications including telephone counselling, videoconferencing and educational 
telephone-based interventions have been favourably received with good acceptability and 
uptake by type 2 diabetes patients.8 Telehealth interventions have also shown efficacy in 
improving psychosocial, psychological and clinical outcomes in diabetes.9 Previous reviews 
of diabetes self-management telehealth interventions have reported the effect of both isolated 
telephone support10 and multi-component interventions.  Whilst behavioural interventions 
and ongoing support are acknowledged as being cornerstones for effective type 2 diabetes 
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self-management,11 the efficacy of behavioural telehealth interventions specifically aimed at 
improving glycaemic control and diabetes self-care remains unexplored.    
 
We have therefore conducted a systematic literature review of the effects of behavioural type 
2 diabetes telehealth interventions. 
 
 
Methods 
The EBSCOHOST research databases CINAHL (Cumulative Index to Nursing and Allied 
Health Literature), Medline and psychINFO were searched using the terms: (diabet* and 
random*) and (tele* or mobile or SMS or smart phone or video* or ehealth).  There was no 
limit on the date of publication. 
 
Eligible studies were peer-reviewed journal articles published in the English language that 
reported evaluating the effects of telehealth interventions on glycaemic control and at least 
one diabetes self-care outcome out of:  physical activity, diet, blood glucose self-monitoring, 
and medication adherence.  Studies had to be randomised controlled trials and included either 
a usual care comparison, or an active treatment control (where the telehealth condition 
received the same treatment).  Included studies had a sample comprising adults (≥18 years) 
with the majority having type 2, rather than type 1 diabetes.  The intervention could not 
primarily be telemonitoring, and must have been exclusively for diabetes management.  
Studies where medication titration was a major component were excluded, as intensive 
medication therapy would confound the effects of behavioural change on glycaemic control.  
Abstracts and titles were screened, and those that appeared to fulfil the eligibility criteria 
were retrieved (as were ones where eligibility was not able to be determined from the 
abstract).  Backward and forward searches of retrieved articles and relevant systematic 
reviews were performed to identify additional potentially eligible studies. 
 
The Cochrane Collaboration’s tool for assessing risk of bias12 was used as a marker for each 
study’s internal validity.  Assessments were performed by indicating a yes/no judgement on 
each of the six domains of validity, and studies deemed to have a high risk of bias were 
excluded from the review.  Data from each study was abstracted and stored in a spreadsheet 
that included the study’s purpose, nature of the intervention, study conditions, outcomes and 
results. 
 
 
Results 
A total of 49 full papers were examined for eligibility, and 14 articles reporting on 13 studies 
were included in the review.  The study processes and outcomes of the included studies are 
summarised in Table 1. 
 
Interventions 
The majority of study interventions involved participants receiving regular telephone calls 
from trained staff (mainly study nurses,13-18 but also psychologists/social workers,19 PhD20 
and Master’s21 students).  An exception was the study by Bell et al.22 in which each 
participant was sent 30- to 60-second video messages via their mobile phone every 24 hours 
on diabetes self-care topics.  Two studies16,23 involved participants receiving automated 
telephone disease management (ATDM) calls to supplement nurses’ follow-up calls.  All 
interventions included diabetes education. 
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The active intervention period ranged from 5 weeks14,18 to 12 months,13,16,17,24 and periods for 
final outcome assessments ranged from 3 months15,20,21 to 12 months post-baseline.13,15-17,22,24  
In most studies (69%), endpoint measures were taken directly post-intervention.  Five studies 
assessed short-term maintenance,14,15,18,22,25 with the longest interval between post-
intervention and final assessments being 6 months.22 
 
Glycaemic control 
Four20-22,24 of thirteen studies reported significant treatment effects on glycaemic control.  
Three also reported significant treatment effects on diabetes self-care.20,21,24  Two20,21 assessed 
all four self-care outcomes in addition to glycaemic control, and reported significant 
improvements in them all.  The majority of significant results for glycaemic control were 
measured directly following the active intervention period, at 3 months20,21 or 12 months.24 In 
Bell et al.’s study,22 significant improvements in HbA1c were seen 3 months into the 6-month 
intervention, but were not maintained at the 6-month post-baseline assessment. 
 
Whilst five studies reported on the dosage of intervention received by intervention group 
participants,14,16,17,22,24 only two of them evaluated dosage relationships with glycaemic 
outcomes.22,24  Both reported significant intervention dosage effects on glycaemic 
improvements.  Walker et al.’s study24 -- a telephone intervention offering ≥10 calls over a 
year -- indicated that intervention group participants completing more than five telephone 
calls had a significantly greater reduction in HbA1c. Bell et al.22 found significant between-
group interactions for HbA1c at the 3-month post-baseline follow-up, but no differences at 12 
months post-baseline, which was 6 months post-intervention.  However, further analyses 
revealed that “persistent viewers” (who viewed >10 video messages a month) experienced a 
significant reduction in HbA1c of 0.6% over 12 months, compared with “early cessation” 
participants who did not view the videos or stopped viewing videos within 2 months post-
enrolment. 
 
Dietary adherence 
Five of eight studies (63%) that assessed the effects of interventions on dietary adherence 
reported significant improvements.13,20,21,24,26  In four of these, dietary improvements were 
found directly following the active intervention.20,21,24,26  There was no notable distinction 
between the type of dietary and lifestyle intervention offered by studies reporting significant 
improvements in diet and ones where no significant effect was found.14,18,25  While Kim & 
Oh’s positive study20 included dietitian reviews of patient meal plans, Trief et al.25 used 
dietary goal setting as the primary focus of their telephone counselling intervention, but 
found no significant dietary improvements.  Differences in the study populations may have 
accounted for the difference in results: in Trief et al.’s study,25 most participants were obese, 
and dietary changes may have presented a significant motivational hurdle. 
 
Physical activity  
Statistically significant treatment effects were reported in five of eight studies (63%) that 
assessed physical activity participation.14,19,21,24,26  Three of these14,19,26 did not find 
improvements in glycaemic control.  Sustained exercise can reduce insulin resistance and 
improve glycaemic control,27 and most studies only tested for effects on glycaemic control 
immediately post-intervention.  A delayed effect of increased physical activity on glycaemic 
control may have occurred, provided that behavioural changes were maintained.  
Furthermore, different types of physical activity (e.g. resistance vs. aerobic) has differential 
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impacts on glycaemia.28  Measures that are sensitive to specific activity changes would help 
to determine the clinical value of reported improvements. 
 
Blood glucose self-monitoring 
Four of nine studies (44%) that measured BGSM found significant improvements in 
frequency.16,17,20,21  Studies reporting significant effects required participants to regularly self-
report their blood glucose levels to the researcher or nurse, indicating possible effects of 
accountability on monitoring.  However, the findings should be interpreted with caution, as 
self-report surveys rather than objective assessments were used both for regular BGSM 
reports during the study and study outcome measures.  Only one study22 provided diabetes 
supplies at no cost to participants.  The cost of increased BGSM may have been a deterrent to 
increasing self-monitoring in some participants. 
 
Medication adherence 
Eight studies assessed medication adherence, with only three17,19,21 (38%) reporting 
significant improvements.  In Walker et al.'s study,24 significant improvements in medication 
adherence were reported on ASK-20 items, but not on items from the Morisky Adherence 
Scale.  Only one study reported the intervention group experiencing significant improvements 
in glycaemia as well as medication adherence.21 However, significant improvements in three 
other diabetes self-care outcome measures relevant to the present review also occurred, and 
those changes may have collectively influenced glycaemic improvements.  The study of 
Walker et al.24 was the only one to compare medication adherence in insulin-dependent 
compared with non-dependent type 2 diabetes:  It found no significant difference between 
these sub-groups. Future studies should include analyses of changes in medication adherence 
within diabetes treatment sub-groups to detect any mediating effects of treatment burden. 
 
Study quality and validity 
Overall, improvements in study quality and validity of reporting are required, with internal 
validity being moderate at best amongst the studies.  In five studies, it was unclear whether 
allocation was concealed,15,19,20,21,25 presenting a risk of exaggerated treatment effects.12  
Most studies used relatively small sample sizes,18-22,25,26 which may have resulted in 
difficulties detecting significant treatment effects.  Trief et al.25 cited individual differences 
between study conditions as a potential source of bias in their results.  Most studies used 
samples comprised mainly of ethnic and socioeconomic minorities,13,14,16,17,19,20-22,24 
presenting problems for external validity. 
 
 
Discussion 
Considerable heterogeneity between study processes and outcomes meant that it was difficult 
to draw firm conclusions.  However, the present review demonstrated that behavioural 
telehealth interventions can significantly improve both glycaemic and diabetes self-care 
outcomes in type 2 diabetes patients.  Of the diabetes self-care outcomes that were examined, 
physical activity and dietary adherence most commonly demonstrated improvements in 
response to telehealth. 
 
The longest study post-intervention follow-up period was only 6 months.22 Longer intervals 
between post-intervention and final endpoint follow-up measures would provide a better 
indication of the longevity of treatment effects and enable detection of “sleeper” (delayed) 
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effects.  This may also assist with determining optimum times for booster appointments in 
real-world implementations of telehealth interventions. 
 
In order to optimise the effect of telehealth for type 2 diabetes, systematic evaluations of 
different dosages and durations of interventions are also needed, as are studies of specific 
subgroups of patients (e.g. insulin dependent/non-dependent).  Only two studies in the 
present review reported relationships between intervention exposure and clinical 
improvements, with both revealing stronger effects from more substantial interventions.22,24 
 
The studies reviewed typically had samples of poorly controlled type 2 diabetes patients.  
Whilst that allows significant treatment effects to be detected, it excludes participants who 
may benefit from a behaviourally focused telehealth intervention.  As shown in Piette et al.16 
and Wolever et al.,19 sub-group analyses according to HbA1c allow the detection of treatment 
effects in cohorts of participants within higher baseline HbA1c ranges.  Undertaking sub-
group analyses may be a solution for including individuals with reasonable glycaemic control 
in behavioural telehealth trials for diabetes.  Furthermore, a focus on community sampling, 
rather than recruiting primarily from diabetes outpatient clinics and/or from minority groups, 
would enable greater generalisability of results.  
 
Finally, research in this field requires substantial improvements in study methodology, 
including blind assessment and allocation concealment.  Clearer reporting of study processes 
and outcomes would enable methodological quality and more confident conclusions to be 
drawn from reviews. 
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Table 1.  Study characteristics [Production -- this table for the online archive] 
Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Interven
tion condition 1 
(3) Interven
tion condition 2 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
Anderson, 
D.R. (2010) 
295 (149 Usual care; 146 Intervention); NR; 58%; 
8.0%; NR; mostly Hispanic or African American; 
Type 2 diabetes 
(1) TAU 
 
(2) Unscript
ed calls from nurse - 
brief clinical 
measures, self-care 
education, BGSM 
review, mailed 
educational 
materials. 
 
 
(2) 12 
months  
Call 
intensities: 
(i) HbA1c ≥ 
9%: weekly, 
(ii)<9%: 
biweekly, 
(iii)≤ 7%: 
monthly. 
 
Follow-up: 6 
& 12 months 
HbA1c: NR 
Diet: Brief Dietary Assessment survey (fruit and vegetable 
intake) 
Physical activity: Rapid Assessment of Physical Activity 
(RAPA) 
 
HbA1c 
NS. 6 & 12 months post-baseline 
- Group x Time. 
NS. Within-group. 
Diet  
N.S. 6 & 12 months post-
baseline – Group x Time. 
NS. Within-group. 
Bell, A.M. 
(2012) 
64 (33 Usual care; 31 Intervention); 58y; 45%; 
9.3%; NR; mostly African American, obese; Type 
1 or 2 diabetes 
(1) TAU: 
Received glucose 
meter and strips, 
broad-band enabled 
cell phone and 
services for 6 
months. 
 
(2) TAU + 
30 – 60-sec video 
SMS’s on diabetes 
self-care topics. 
 
 
 
 
(2) 6 months 
SMS’s: 24-
hourly. 
 
Follow-up: 3, 
6, 9 & 12 
months 
HbA1c: High performance liquid chromatography (HPLC; 
COBAS C 111 Analyzer) 
 
BGSM: Data upload frequency. 
HbA1c 
*3-months post-baseline – 
Group x time (P=.02).  
NS. 6-, 9- & 12-months post-
baseline. 
NS. Within-group. 
BGSM 
NS. Group x Time. 
NS. Within-group. 
Frosch, D.L. 
(2011) 
201 (100 Usual care; 101 Intervention); 55.5y; 
48.5%; 9.6%; 10y; mostly African American or 
Latino & obese; Type 2 diabetes 
(1) TAU: 
Received 20-page 
diabetes education 
brochure. 
 
(2) TAU + 
24-minute DVD 
program; booklet 
“Living with 
Diabetes” + phone 
coaching sessions 
 
 
 
(2) 5 weeks 
≤ five phone 
sessions. 
Session 1: 
≤60 min; 2 & 
3:≤30 min; 4 
& 5:≤15 min. 
 
HbA1c: HPLC 
 
Diet, exercise, BGSM, medication: Summary of Diabetes Self-
Care Activities (SDSCA) Survey 
HbA1c 
NS. Group x Time.  
*Time effects across groups 
(P<.001). 
Diet 
NS. Group x time.  
*Time effects across groups 
(P<.001).  
Exercise 
* 6 months post-baseline – 
Group x Time (P=.04). 
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with diabetes nurse. Follow-up: 1 
& 6 months 
NS. Time effects across groups. 
BGSM 
NS. Group x Time. 
*Time effects across groups 
(P=.03). 
Medication 
NS. Group x Time: (i) taking 
most medications, (ii) all 
medications.  
* 1 & 6 months post-baseline - 
Time effects across groups, (i) 
(P=.01), (ii) (P<.001). 
Kim, H. (2003) 50 (25 control; 25 intervention); 60.3y; 70%; 
8.5%; 13.7y; South Koreans, half < middle 
school; Type 2 diabetes 
(1) TAU 
 
(2) Diabetes care 
booklet & daily diet 
log; phone calls 
from PhD student - 
continuing 
education, 
reinforcement of 
diet & exercise; 
medication 
recommendations & 
frequent BGSM. 
Diet 
recommendations 
mailed from 
Dietitian after daily 
diet log review.  
 
 
(2) 3 months  
Calls ≥ 
twice/wk for 
1 mth; 
weekly for 
months 2 & 
3. 
Calls, M=25 
min. 
Follow-up: 3 
months 
HbA1c: HPLC (Variant II, Bio-Rad Hercules) 
 
Diet, exercise, blood glucose testing, medication-taking: Self-
Reported Adherence Questionnaire (Kim, 1999) 
HbA1c 
*Group x Time (P=.0001). 
* Within-group: intervention 
decline (P<.05); control increase 
(P<.05). 
Diet 
*Group x time (P=.006).  
*Within-group improvement - 
intervention (P<.05). 
Exercise 
NS. Group x time. 
NS. Within-group. 
BGSM 
*Group x time (P=.024). 
*Within-group improvement - 
intervention (P<.05). 
Medication 
NS. Group x time. 
NS. Within-group. 
Maljanian, R. 
(2005) 
336 (160 control, 176 intervention); 58y; 53.3%; 
7.9%; NR; mostly Caucasian, overweight; Type 1 
or 2 diabetes 
(1) TAU: 3 diabetes 
education classes; 
individual visits 
with Registered 
Nurse & 
Nutritionist; 
collaborative care 
management with 
written evaluations 
and 
recommendations 
for Primary Care 
Provider. 
 
(2) TAU + phone 
calls from Research 
(1) Classes= 
4 hours each 
 
 
 
 
 
(2) 3 months 
 Calls: 
weekly. Call 
1, M=15-20 
min; other 
calls, M=5-7 
min. 
Follow-up: 3 
& 12 months 
HbA1c: HPLC (Bayer DCA 2000 Analyzer) or collected from 
participant’s Physician 
 
BGSM: Diabetes Quality Improvement Project (DQIP) items 
HbA1c 
NS. Group x time. 
NS. Within-group. 
BGSM 
NS. Group x time. 
NS. Within-group. 
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Nurse - education & 
self-management 
skills reinforcement. 
Nesari, M. 
(2010) 
61 (31 control; 30 intervention); 51.6y; 71.7%; 
9.0%; NR; mostly Iranian, overweight; Type 2 
diabetes 
(1) TAU: 3-day 
diabetes self-care 
education program. 
 
(2) TAU + phone 
calls from Master’s 
nursing student on 
health behaviours, 
education, & 
medication 
adjustment 
according to 
glucose levels. 
(1)Each 
session =60 
min (3/day) 
 
(2) 3 months 
Calls: 
twice/wk for 
1 mth; 
weekly for 
months 2 & 
3. 
Calls, M=20 
min. 
Follow-up:  3 
months 
HbA1c: HPLC (Pars Azemoo) 
 
Diet, exercise, BGSM, medication-taking: Level of adherence; 
Self-reported questionnaire (developed by research staff)  
HbA1c 
*3 months post-baseline – 
intervention better. (P<.001). 
* Within-group decline - 
intervention (P<.001). 
Diet 
*3 months- intervention better 
(P<.001).  
*Within-group improvement – 
both groups (P<.001). 
Exercise 
*3 months post-baseline – 
intervention better (P<.001). 
*Within-group increase - 
intervention (P<.001). 
BGSM 
*3 months post-baseline – 
intervention better (P<.001). 
NS. Within-group. 
Medication 
*3 months post-baseline – 
intervention better. (P=.001). 
*Within-group increase – 
intervention (P<.001) 
Piette, J.D. 
(2001) 
272 (140 control; 132 intervention); 60.5y; 
28.65%; 8.1%; NR; department of veterans affairs 
patients, overweight; Type 1 or 2 diabetes 
(1) TAU 
 
(2) Outbound 
automated 
telephone disease 
management 
(ATDM) calls with 
self-assessments 
(BGSM readings, 
self-care activities, 
symptoms, medical 
care use); health 
promotion messages 
(optional) + nurse 
follow-up 
 
 
(2) 12 
months 
ATDM calls: 
biweekly, 
M= 5- 8 min 
(+ promotion 
messages); 
nurse calls: 
weekly, 
M=29 min. 
Follow-up:12 
months 
HbA1c: NR 
 
BGSM, medication-taking (problems): NR (phone interview) 
HbA1c 
NS. Between-groups. 
*12 months post-baseline – 
Baseline HbA1c ≥8.0% - 
intervention better (P=.04); 
Baseline HbA1c ≥9.0% - 
intervention better (P=.04). 
BGSM 
*12 months post-baseline – 
intervention better (P=.05). 
N.S. Within-group. 
Medication 
NS. Between-groups. 
NS. Within-group. 
Piette, J.D. 
(2000) 
280 (124 control; 124 intervention); 54.5y; 73%; 
8.7%; NR; mostly Hispanic or Caucasian, 
overweight; Type 1 or 2 diabetes 
(1) TAU 
 
(2) Outbound 
ATDM calls with 
self-assessments 
 
 
(2) 12 
months 
ATDM calls: 
HbA1c: NR 
 
BGSM, medication: Self-report survey questions 
HbA1c 
NS. Group x time. 
BGSM 
*12 months post-baseline - 
intervention better (P=.03). 
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(BGSM readings, 
self-care, 
symptoms, medical 
care use); “health 
tips”, diet & 
exercise self-care 
module (optional) + 
nurse follow-up 
biweekly, 
M=5-14 min; 
nurse calls: 
weekly, 
M=20 min.  
Follow-up:12 
months 
NS. Within-group.
Medication  
*12 months post-baseline – 
intervention better (P=.003). 
 
Sacco, W.P. 
(2011), Sacco, 
W.P. (2009) 
62 (31 control; 31 intervention); 52y; 58%; 8.5%; 
9.5y; mostly Caucasian, obese; Type 2 diabetes 
(1) TAU 
 
(2) Phone coaching 
- BGSM review to 
identify causes of 
“out of range” 
readings; help 
translating broad 
goals into weekly 
implementation 
intentions; problem-
solving; 
reinforcement of 
positive changes. 
 
 
(2) 6 months 
Weekly calls 
– 3 months; 
biweekly – 3 
months. 
Initial intake 
call, M= 
53.63 min; 
other calls, 
M= 17.38 
min. 
Follow-up: 6 
months 
HbA1c: Baseline - medical records (majority HPLC; Bayer 
DCA 2000 Analyzer); follow-up – lab values 
 
Diet, exercise, BGSM, medication: SDSCA Survey 
HbA1c 
NS. Group x time. 
Diet 
*Group x time (P<.05). 
Exercise 
*Group x time (P<.001). 
BGSM 
NS. Group x time. 
Medication 
NS. Group x time. 
Sigurdardottir, 
A.K. (2009) 
53 (25 control; 28 intervention); 60.7y; 32%; 
8.0%; 8.7y; mostly overweight; Type 2 diabetes 
(1) TAU 
 
(2) One face-to-face 
session with Nurse 
Educator - diabetes 
knowledge, dietary 
& exercise 
behaviour survey 
items; guided goal-
setting; discussed 
obstacles to change; 
then five phone 
coaching sessions. 
 
 
(2) 5 weeks 
Face-to-face 
session = 1-2 
h; five calls, 
M= 15-20 
min. 
Follow-up: 3 
& 6 months 
HbA1c: NR 
 
Diet, exercise, BGSM: 12 Items from SDSCA Survey 
HbA1c 
NS. Group x time. 
*3 months baseline – within-
group decline – both (P<.05). 
NS. 6 months post-baseline – 
within-group. 
Diet 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.027). 
Exercise 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.045). 
BGSM 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.013). 
Trief, P. (2011) 44 (13 control; 12 individual intervention; 12 
couples intervention); 59.9y; 63.6%; 8.3%; 13.4y; 
mostly obese, all couples – 1 partner with T2D 
(1) TAU: Two 
diabetes education 
sessions & meal 
 
 
 
HbA1C: HPLC (DCA 2000 A1C Analyzer) 
 
Diet, BGSM: SDSCA Survey 
HbA1c 
NS. Group x time. 
NS. Within-group. 
13 
plan review by 
phone. 
 
(2) Individual: TAU 
+ phone sessions on 
dietary goal-setting, 
two on emotions re. 
Diabetes 
 
(3) Couples: TAU + 
phone sessions 
including partner on 
collaborative 
problem-solving. 
(2 & 3) 3 
months 
Nine phone 
sessions. 
Follow-up: 3 
& 6 months 
Diet 
NS. Group x time. 
NS. Within-group. 
BGSM 
NS. Group x time. 
NS. Within-group. 
Walker, E.A. 
(2011) 
526 (264 control; 262 intervention); 55.5y; 
67.1%; 8.6%; 9.2y; mostly Black and Hispanic, 
overweight; Type 2 diabetes 
(1) TAU: Diabetes 
education materials 
mailed after 
randomisation. 
 
(2) TAU + phone 
calls from Health 
Educator -
medication 
adherence, problem-
solving, goal-
setting, 
communication, 
planning medical 
visits, diet, physical 
activity. 
 
 
 
 
(2) 12 
months 
≥10 calls, 4- 
to 6-week 
intervals, 
M=14.1 min. 
Follow-up: 
12 months 
HbA1c: “Dry-dot” Method (mail-out kits) 
 
Diet (number days/week following healthy eating plan); 
exercise (number days ≥30 min exercise); self-care: SDSCA 
survey; medication: Morisky Adherence Scale 
HbA1c 
*Group x time (P=.009). 
Diet 
*Group x time (P<.05). 
Exercise 
*Group x time (P<.05). 
Medication  
NS. Group x time. 
Wolever, R.Q. 
(2010) 
56 (26 control; 30 intervention); 53y; 77%; 8.0%; 
11y; mostly African American; Type 2 diabetes 
(1) TAU 
 
(2) Integrative 
Health coaching by 
phone with trained 
social worker/ 
psychology 
graduate coaches. 
Guided in creating 
vision of health and 
long-term goals. 
Wheel of Health 
used to guide 
conversations; 
received educational 
materials. 
 
 
(2) 6 months  
8 weekly 
calls; 4 
biweekly. 
Final call 1 
mth later. 
Calls, M=30 
min. 
Follow-up: 6 
months 
HbA1c: lab values 
 
Exercise - (How many times/week exercised ≥ 15-20 minutes in 
past mth)” 
Medication: Morisky Adherence Scale, ASK-20 items. 
HbA1c 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
HbA1c≥7% (P=.03). 
Exercise 
*Group x time (P=.026). 
Medication 
*Group x time, ASK-20 survey 
(P=.036). 
NS. Group x time – Morisky 
Adherence Scale 
*6 months post-baseline – 
within-group – intervention 
(ASK-20, P=.001; Morisky, 
P=.004)
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NR, not reported 
NS, not significant (P>0.05) 
*P<0.05 
TAU, treatment as usual 
 
